Jeff Gladden, MD

Member

Dr. Gladden has been practicing in North Texas since 1988. He founded Advanced Heart Care in 1997. Professionally, Dr. Gladden has quite a few interests and areas of expertise including interventional cardiology (coronary artery disease, angioplasty, stents, rotablation athrectomy, eximer laser athrectomy, intracoronary ultrasound, enhanced external counterpulsation, and brachytherapy), in diagnostic cardiology (nuclear cardiology, echo and stress echocardiography, and transesophageal echocardiography), and in preventive cardiology (cardiac rehabilitation, cholesterol lowering, smoking cessation, and nutritional supplementation).

Medical Education

• Temple University

Residency & Fellowship

• Internship in Internal Medicine at the University Hospitals of Cleveland, Case Western University, in Cleveland OH (1982-1983)
• Residency in Internal Medicine at the University Hospitals of Cleveland, Case Western University, in Cleveland OH (1983-1985)
• Fellowship in Cardiology at the University of Colorado Health Sciences Center in Denver CO (1985-1988)

Licensure & Board Certifications

• Board Certified by the American Board of Internal Medicine in Interventional Cardiology (1999)
• Board Certified by the American Board of Internal Medicine in Nuclear Cardiology (1999)
• Fellow of the American College of Cardiology (1991)
• Board Certified by the American Board of Internal Medicine in Cardiovascular Disease Sub-specialty (1989)
• Board Certified by the American Board of Internal Medicine (1985)
• Diplomat of the National Board of Medical Examiners (1983)
• McCurtain Memorial

Professional Memberships

• American College of Cardiology
• American Heart Association
• American College of Physicians
• American Medical Association
• Dallas County Medical Society
• Texas Medical Association

Other

Dr. Gladden co-founded the Heart Hospital at Baylor Plano and currently serves on the Board of Directors.

---

Sunil Gupta

Member

As founder and guiding force behind Retina Specialty Institute, Dr. Gupta devotes his heart, mind and intuition to the science and art of the retina. He draws a parallel between people's ability to see and their overall quality of life and is determined to enhance both. Dr. Gupta respects patients as equal partners in their care.

Dr. Gupta set out studying engineering, but after completing an internship that intersected with medicine, he realized his true calling was that of a physician. He went to medical school and discovered his love for ophthalmology - something he wanted to be the authority in by specializing in the retina.

He has witnessed tremendous progress in his field and forecasts the next 10 to 15 years will lead to unprecedented, life-changing advances.

• Renowned investigator of clinical trials based on a steadfast commitment to discovering better drugs and new treatments for patients
• Serves on the Retinal Advisory Committee (R.A.C.) for Alcon, the largest Ophthalmology company in the world
• Serves on the Retina Advisory Board for Allergan
• Chairman of the Board of Managers of Andrews Institute Ambulatory Surgery Center, December 2010 - December 2013
• Board certified, American Board of Ophthalmology
• Fellowship, Surgical & Medical Retina, University of Iowa
• Chief Resident, Department of Ophthalmology, Baylor College of Medicine
• Honors Graduate, University of Cincinnati, College of Medicine

---

Barbara McAneny, MD

Member

Dr. Barbara McAneny is the CEO of the New Mexico Cancer Center, the first freestanding healthcare facility exclusively devoted to cancer treatment and blood disorders in the state. The center handles approximately 35% of all cancer cases in New Mexico. The New Mexico Cancer Center has sites in Albuquerque, Gallup, Silver City, and Ruidoso.

Dr. McAneny is a Board-Certified medical oncologist, hematologist and general internist. On the regional level, she is past president of the New Mexico Medical Society (2000), and was past-president of the Greater Albuquerque Medical Association (1987), and past President of the New Mexico Chapter of the American College of Physicians. She works on multiple public health projects, including being the current Chair of the Emergency Medical Services Authority for the City of Albuquerque and County of Bernalillo, she was past Chair of the State of New Mexico Tobacco Prevention Coordinating Council, and has spent 20 years working on various New Mexico Department of Health projects.

On the national level, she serves the American Society of Clinical Oncology as its delegate to the American Medical Association. Dr. McAneny served a three-year term on the ASCO Board of Directors. She is currently Chair-elect for the Professional Development Committee of ASCO and a long time member of the ASCO Clinical Practice Committee. Doctor McAneny served a four year term on the Practicing Physicians Advisory Council, a congressionally mandated organization comprised of 15 physicians nationwide designated as the advisory council to the Secretary of Health and Human Services, which runs Medicare/Medicaid. Currently, she is Chair of the AMA Council on Medical Services, which develops health policy for the AMA. Dr. McAneny is also an active member of the Association of Community Cancer Centers. She is a founding member of Oncology Circle, a collaborative, knowledge-sharing national network of community-based oncology practices.

---

Robert W. McElearney

Member

Mr. McElearney provides overall leadership for the company in partnering with health systems, hospitals and physicians to developing the company's core strengths in diagnostic imaging, radiation oncology, and outpatient services. He spearheads the company's effort to identify new business opportunities and optimize the value of affiliations with a wide variety of providers and industries in the health care arena.

Mr. McElearney's background in health care spans almost 20 years, working in every part of the country in senior positions of leadership in the healthcare industry. He led Business Development for the nation's largest provider of mobile imaging services, directing its effort to expand into new business areas.

As Vice President for TenetCare, a Tenet subsidiary, he developed freestanding ASC/imaging facilities nationwide; as a Senior VP with Columbia/HCA he led strategic planning for a large group of hospitals in the southwest. He was Senior VP of a national investment bank, leading their health care division. Mr. McElearney also served as Director with KPMG Consulting, Regional Manager for Business Development with Universal Health Services, and co-founded a 100,000 life TPA Company. He holds an MBA in Business Administration from Wright State University, Ohio.

---

Jay H. Sanders, MD

Member

Dr. Sanders is the CEO of The Global Telemedicine Group, Professor of Medicine (Adjunct) at Johns Hopkins School of Medicine and a Founding Board Member and President Emeritus of the American Telemedicine Association. Known to many as the "Father of Telemedicine", he developed the first statewide telemedicine system, the first Correctional telemedicine program, the first tele-homecare technology, called "The Electronic House Call", and the first telemedicine kiosk. His consulting activities have included NASA, DOD, HHS, the FCC, State Governments, WHO, and multiple academic institutions and Fortune 500 companies.

During the Clinton Administration he represented the USA to the G8 nations for telemedicine, and was appointed by former HHS Secretary Leavitt, to the Chronic Care Workgroup Committee. He is a graduate of Harvard Medical School, magna cum laude, a member of AOA, and did his residency training at the Massachusetts General Hospital where he became Chief Medical Resident.

In 1970, he developed and started the first Division of General Medicine in the country at the University of Miami where he was Professor of Medicine and Chief of Medicine at Jackson Memorial Hospital. Other academic appointments include being Professor of Medicine and Surgery at the Medical College of Georgia, where he was Director of the Telemedicine Institute, and Visiting Professor at the Hospital of the University of Pennsylvania and Yale University School of Medicine.